AbiertoNCT06526117Ver en ClinicalTrials.gov ↗⚑ Reportar un problema con este anuncio

Stroke Prevention in Nigeria 2 Trial

Mostrando el original en inglés

Primary Prevention of Stroke in Children With SCD in Sub-Saharan Africa II: A Multicenter, Open-label, Single-arm Type I Hybrid Clinical Trial

Afección específica por raza/etnia

Fase

PHASE4

Inscripción

220 (estimado)

Rango de edad

5 Years to 12 Years

Sexo

ALL

Resumen

The primary goal of this study is to complete a multicenter single-arm, type I hybrid trial to assess the effectiveness of hydroxyurea therapy for primary stroke prevention in high-risk children with sickle cell anemia (SCA) living in Nigeria in routine care settings.

Mostrando el original en inglés

Afecciones estudiadas

Sickle Cell DiseaseStroke

Patrocinadores

Aminu Kano Teaching HospitalColaborador

Murtala Muhammed Specialist HospitalColaborador

National Institute of Neurological Disorders and Stroke (NINDS)Colaborador

Vanderbilt University Medical CenterPrincipal

Ubicaciones del estudio

Aminu Kano Teaching Hospital

Kano

Shehu U Abdullahi, MD, FWACPaed, CONTACT

Murtala Muhammad Specialist Hospital

Kano

Salma A Suwaid, MBBS FWACP, CONTACT